A Different Level of Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics of Bilastine in a Chinese Population
Phase of Trial: Phase I
Latest Information Update: 17 Jan 2019
At a glance
- Drugs Bilastine (Primary)
- Indications Allergic conjunctivitis; Allergic rhinoconjunctivitis; Perennial allergic rhinitis; Pruritus; Seasonal allergic rhinitis; Urticaria
- Focus Pharmacokinetics
- Sponsors Menarini Asia-Pacific
- 08 Jan 2019 Planned End Date changed from 30 Jan 2019 to 31 Jul 2019.
- 08 Jan 2019 Planned primary completion date changed from 30 Nov 2018 to 30 Apr 2019.
- 30 Aug 2018 Planned End Date changed from 30 Nov 2018 to 30 Jan 2019.